业界动态国内医卫资讯

萨瑞鲁单抗在降低风湿性多肌痛患者激素用量方面可能优于甲氨蝶呤

Medscape News · 2026-11-11 16:27

摘要

真实世界数据提示,萨瑞鲁单抗可能比甲氨蝶呤具有更大的激素节约获益,尽管治疗选择仍取决于患者个体因素。Medscape Medical News

English
Sarilumab May Beat Methotrexate to Lower Steroid Use in PMR

Real-world data suggest sarilumab may offer greater steroid-sparing benefits than methotrexate, although treatment choice still depends on individual patient factors. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界